Woodline Partners’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $23.9M | Sell |
|
|||||
|
2025
Q2 | $17.7M | Buy |
|
|||||
|
2025
Q1 | $23.2M | Hold |
|
|||||
|
2024
Q4 | $25M | Sell |
|
|||||
|
2024
Q3 | $36.5M | Buy |
|
|||||
|
2024
Q2 | $31.7M | Buy |
|
|||||
|
2024
Q1 | $36.8M | Buy |
|
|||||
|
2023
Q4 | $33.4M | Buy |
|
|||||
|
2023
Q3 | $495K | Sell |
|
|||||
|
2023
Q2 | $12.8M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $19M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $6.79M | Sell |
|
|||||
|
2021
Q3 | $11.1M | Buy |
|
|||||
|
2021
Q2 | $3.57M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.73M | Buy |
|